Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Resectable Non-Small Cell Lung Cancer × Nivolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 15 Carcinoma, Non-Small-Cell Lung 12 Squamous Cell Carcinoma of Head and Neck 6 Colorectal Neoplasms 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Neoplasms 3 Multiple Myeloma 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Hepatocellular 2 Adenocarcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Resectable Non-Small Cell Lung Cancer 1 Resectable Hepatocellular Carcinoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡